Negative Pressure Wound Therapy for Closed Surgical Wounds in Musculoskeletal Oncology Patients - A Case-Control Trial



Roderick Kong, David Shields, Oliver Bailey, Sanjay Gupta*, Ashish Mahendra
Department of Musculoskeletal Oncology, Glasgow Royal Infirmary, 84 Castle Street, Glasgow, G4 0ET Scotland, United Kingdom


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 284
Abstract HTML Views: 212
PDF Downloads: 104
ePub Downloads: 67
Total Views/Downloads: 667
Unique Statistics:

Full-Text HTML Views: 207
Abstract HTML Views: 146
PDF Downloads: 66
ePub Downloads: 56
Total Views/Downloads: 475



© 2017 Kong et al.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the Department of Musculoskeletal Oncology, Glasgow Royal Infirmary, 84 Castle Street, Glasgow, G4 0ET Scotland, United Kingdom; Tel: 416 939 3236; E-mail: sanjaygupta@doctors.org.uk


Abstract

Following excision of musculoskeletal tumours, patients are at high risk of wound issues such as infection, dehiscence and delayed healing. This is due to a multitude of factors including the invasive nature of the disease, extensive soft tissue dissection, disruption to blood and lymphatic drainage, residual cavity and adjuvant therapies. The use of negative pressure wound therapy (NPWT) has a growing body of evidence on its beneficial effect of wound healing such as promoting cell differentiation, minimising oedema and thermoregulation. Traditionally, these dressings have been used for open or dehisced wounds; however recent research has investigated its role in closed wounds.

Aim:

To evaluate the effect of NPWT in patients with closed wounds, either primarily or with flap coverage, in our high risk group. Consecutive patients who had a NPWT dressing applied were selected, and a control group was established by a blinded researcher with matching for tissue diagnosis, surgical site, gender and age. The primary outcome measured was documented for wound complications, with secondary data collected on radiotherapy and wound drainage.

Results:

Patients were well matched between the intervention (n=9) and control (n=9) groups for gender, age and tissue diagnosis. Both groups had 1 patient who underwent preoperative radiotherapy. A total of 3 wound infections occurred in the control group and none in the NPWT group. Overall there was a trend towards lower drain output and statistically significantly reduced infection rate in the NPWT group.

Conclusion:

In this short series, despite the NPWT patients having more additional risk factors for wound issues, they resulted in fewer infections. The sample size is not sufficient to have statistically significant reduction. Further evaluation on the value of NPWT in this patient group should be prospectively evaluated.

Keywords: Sarcoma, Negative pressure, Wound, Infection, Surgical site infection, Dressings.